Report : North America Antibiotics Market Forecast to 2027 - Covid-19 Impact and Regional Analysis by Drug Class (Sulfonamides, Aminoglycosides, Carbapenem, Macrolides, Fluoroquinolones, Penicillin, Cephalosporin, Others); Action Mechanism (Mycolic Acid Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors); and Country
The CephalosporinsSegment Held Largest Share of Asia Pacific Antibiotics Market in 2019
According to The Insight Partners market research study of ‘North America Antibiotics Marketto 2027 – Regional Analysis and Forecasts by Drug Class and Action Mechanism,’the North America antibiotics market is expected to reach US$18,004.25 millionby 2027 from US$ 13,527.79 million in 2019. The market is estimated to grow with a CAGR of 3.9% from 2020 to 2027. The report provides trends prevailing in the North Americaantibiotics market and the factors driving market along with those that act as hindrances.
Based on drug class, the antibiotics market is segmented into sulfonamides, aminoglycosides, carbapenem, macrolides, fluoroquinolones, penicillin, cephalosporin, and others. The cephalosporin segment held the largest share of the market in 2019, whereas the fluoroquinolones segment is anticipated to register the highest CAGR in the market during the forecast period.Cephalosporins have continued to serve as one of the largest class of antibiotics since their discovery in the 1950s. These antibiotics are capable of treating infections that have mild life-threatening impact.
The North Americaantibiotics marketis expected to grow owing to the prevalence of infectious diseases, and increasing development of generic drugs. However, tedious and expensive process of antibiotic development and the impact of COVID-19 pandemicis expected to restrain the growth of the market during the forecast period.
North AmericaAntibiotics Market– ByDrug Class
North America Antibiotics Market– ByAction Mechanism
North America Antibiotics Market– By Geography
Contact Person: Sameer Joshi
Email Id: email@example.com